Weight management for children with severe obesity

    Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
    |September 30, 2016
    PubMed

    Insights

    A stepped care approach using the SHINE model offers a sustainable, integrated pathway for managing severe childhood obesity, especially where services are limited. This holistic model emphasizes self-management, support, independence, nutrition, and exercise for young people.

    Area of Science:

    • Public Health
    • Pediatric Obesity Management

    Background:

    • Weight management services are often underdeveloped in primary care settings.
    • Sustaining positive outcomes in pediatric weight management requires integrated and accessible approaches.

    Purpose of the Study:

    • To propose an integrated, stepped care model for managing severe obesity in children and young people.
    • To outline the SHINE (Self, Help, Independence, Nutrition and Exercise) model as a practical framework.

    Main Methods:

    • The article suggests a stepped care framework.
    • The SHINE model is presented as a tool for implementing this framework.
    • Focus on a holistic and integrative care pathway.

    Main Results:

    • The SHINE model provides a structured approach to care.
    • This model facilitates a holistic pathway for children and young people.
    • It addresses key components of weight management: self-care, support, independence, nutrition, and exercise.

    Conclusions:

    • The SHINE stepped care model is a viable approach for primary care settings lacking established weight management services.
    • This integrated model supports sustainable weight management in pediatric populations.
    • It offers a holistic and practical solution for severe childhood obesity.

    Related Concept Videos

    Drug Dosing: Obese Patients01:21

    Drug Dosing: Obese Patients

    In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
    325
    Obesity01:24

    Obesity

    The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
    1.5K
    Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

    Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

    Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
    343
    Insulin: Dosing Regimen and Adverse Effects01:16

    Insulin: Dosing Regimen and Adverse Effects

    Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
    The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
    1.0K
    Drug Dosing: Infants and Children01:29

    Drug Dosing: Infants and Children

    Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
    677
    Binge Eating Disorders01:23

    Binge Eating Disorders

    Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
    670